SUNPHARMA — Sun Pharmaceutical Industries Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹3.61tn
- IN₹3.51tn
- IN₹438.86bn
- 96
- 13
- 99
- 84
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 111,827 | 113,666 | 95,633 | 127,169 | 151,477 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 95,448 | 99,257 | 93,248 | 121,851 | 129,598 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 310,692 | 316,542 | 304,421 | 348,646 | 398,619 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 109,382 | 112,263 | 111,715 | 111,689 | 113,537 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 646,938 | 682,525 | 676,667 | 698,078 | 807,436 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 173,396 | 157,064 | 161,456 | 172,085 | 199,064 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 232,848 | 229,880 | 212,040 | 217,966 | 247,482 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 414,091 | 452,645 | 464,628 | 480,112 | 559,954 |
Total Liabilities & Shareholders' Equity | 646,938 | 682,525 | 676,667 | 698,078 | 807,436 |
Total Common Shares Outstanding |